Literature DB >> 19567248

Impact of excess aldosterone on glucose homeostasis in adult male rat.

Jayaraman Selvaraj1, Thirupathi Muthusamy, Chinnapaiyan Srinivasan, Karundevi Balasubramanian.   

Abstract

BACKGROUND: Clinical and experimental data demonstrate that excess aldosterone and insulin interact at target tissues. It has been shown that increased levels of aldosterone contribute to development of insulin resistance and thus act as a risk factor for the development of type-II diabetes mellitus. However, the molecular mechanisms involved are yet to be identified. The present study was designed to assess the impact of excess aldosterone on GLUT2 and GLUT4 gene expression and glucose uptake in liver and skeletal muscles (gracilis and quadriceps) of adult male rat.
METHODS: Healthy adult male albino rats of Wistar strain (Rattus norvegicus), weighing 180-210 g were used in the present study. The rats were divided into two groups (control and aldosterone treated) each consisting of five animals. Rats were treated with aldosterone at a dose of 10 microg/kg body weight, subcutaneously, twice daily at 8 AM and 6 PM for 15 days.
RESULTS: Excess aldosterone impaired the rate of glucose uptake through defective expression of GLUT2 and GLUT4 genes and also decreased translocation of GLUT4 to the plasma membrane.
CONCLUSION: Excess aldosterone has an adverse effect on glucose uptake in liver and skeletal muscle and the defective expression of GLUT2 and GLUT4 appears to be responsible for such changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567248     DOI: 10.1016/j.cca.2009.06.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Aldosterone aggravates glucose intolerance induced by high fructose.

Authors:  Shamshad J Sherajee; Kazi Rafiq; Daisuke Nakano; Hirohito Mori; Hideki Kobara; Hirofumi Hitomi; Yoshihide Fujisawa; Hiroyuki Kobori; Tsutomu Masaki; Akira Nishiyama
Journal:  Eur J Pharmacol       Date:  2013-11-04       Impact factor: 4.432

2.  Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.

Authors:  Prafull Raheja; Angela Price; Zhongyun Wang; Debbie Arbique; Beverley Adams-Huet; Richard J Auchus; Wanpen Vongpatanasin
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

Review 3.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

4.  RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Kimberly Wong; Martin Torriani; Caitlin Mayhew; Takara Stanley; Janet Lo; Gail K Adler; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2015-06-18       Impact factor: 5.958

5.  The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity.

Authors:  Carrie A Northcott; Greg D Fink; Hannah Garver; Joseph R Haywood; Erinn L Laimon-Thomson; Jonathon L McClain; Paulo W Pires; William E Rainey; Christine S Rigsby; Anne M Dorrance
Journal:  Endocrinology       Date:  2012-02-21       Impact factor: 4.736

6.  Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat.

Authors:  Jayaraman Selvaraj; Sampath Sathish; Chinnaiyan Mayilvanan; Karundevi Balasubramanian
Journal:  Mol Cell Biochem       Date:  2012-09-25       Impact factor: 3.396

Review 7.  Effects of aldosterone on insulin sensitivity and secretion.

Authors:  James M Luther
Journal:  Steroids       Date:  2014-09-04       Impact factor: 2.668

Review 8.  Negative effects of chlorthalidone on sympathetic nervous system and insulin resistance in hypertensive patients may be avoided with spironolactone: further studies are still needed.

Authors:  Y Castro-Torres; A Fleites-Pérez; R Carmona-Puerta; R G Jiménez-Garrido
Journal:  Ir J Med Sci       Date:  2015-09-04       Impact factor: 1.568

Review 9.  Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?

Authors:  Huai Heng Loh; Norlela Sukor
Journal:  J Hum Hypertens       Date:  2019-12-10       Impact factor: 3.012

10.  Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.

Authors:  Shivraj Grewal; Andin Fosam; Liam Chalk; Arjun Deven; Mari Suzuki; Ricardo Rafael Correa; Jenny E Blau; Andrew Paul Demidowich; Constantine A Stratakis; Ranganath Muniyappa
Journal:  Endocrine       Date:  2021-01-18       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.